|
EP1789391B1
(en)
|
2004-07-23 |
2017-06-28 |
Endocyte, Inc. |
Bivalent linkers and conjugates thereof
|
|
CA2680535C
(en)
|
2007-03-14 |
2016-09-20 |
Endocyte, Inc. |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
CA2690943A1
(en)
|
2007-06-25 |
2008-12-31 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
US10080805B2
(en)
|
2012-02-24 |
2018-09-25 |
Purdue Research Foundation |
Cholecystokinin B receptor targeting for imaging and therapy
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
US20140079636A1
(en)
|
2012-04-16 |
2014-03-20 |
Dinesh U. Chimmanamada |
Targeted therapeutics
|
|
ES2887208T3
(es)
|
2012-05-15 |
2021-12-22 |
Concortis Biosystems Corp |
Conjugados de fármacos y usos de los mismos
|
|
IN2015DN04147A
(cg-RX-API-DMAC7.html)
|
2012-10-16 |
2015-10-16 |
Endocyte Inc |
|
|
RU2015129800A
(ru)
|
2012-12-21 |
2017-01-30 |
Биоэллаенс К. В. |
Гидрофильные саморазрушающиеся линкеры и их конъюгаты
|
|
CN110143999B
(zh)
|
2013-03-15 |
2023-12-05 |
酵活英属哥伦比亚省公司 |
具细胞毒性和抗有丝分裂的化合物以及其使用方法
|
|
CA2914448A1
(en)
|
2013-06-12 |
2014-12-18 |
Muhammad Naveed Yousaf |
Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof
|
|
WO2015038649A1
(en)
|
2013-09-10 |
2015-03-19 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
CA3187392A1
(en)
|
2013-10-15 |
2015-04-23 |
Seagen Inc. |
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
|
|
RU2016134258A
(ru)
|
2013-10-15 |
2018-02-28 |
Сорренто Терапьютикс Инк. |
Конъюгат лекарственного средства с направляющей молекулой и двумя различными лекарственными средствами
|
|
WO2015066053A2
(en)
|
2013-10-28 |
2015-05-07 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
KR20160125361A
(ko)
|
2013-12-27 |
2016-10-31 |
자임워크스 인코포레이티드 |
Ｖａｒ２ｃｓａ－약물 접합체
|
|
JP6560681B2
(ja)
|
2013-12-27 |
2019-08-14 |
ザイムワークス インコーポレイティド |
薬物結合体のためのスルホンアミド含有連結系
|
|
AU2015213106B2
(en)
*
|
2014-01-28 |
2019-07-25 |
Tube Pharmaceuticals Gmbh |
Cytotoxic tubulysin compounds for conjugation
|
|
JP2017505777A
(ja)
|
2014-01-29 |
2017-02-23 |
シンタ ファーマスーティカルズ コーポレーション |
標的化治療薬
|
|
GB201402006D0
(en)
*
|
2014-02-06 |
2014-03-26 |
Oncomatryx Biopharma S L |
Antibody-drug conjugates and immunotoxins
|
|
EP3129064B1
(en)
|
2014-03-03 |
2020-01-01 |
Madrigal Pharmaceuticals, Inc. |
Targeted therapeutics
|
|
EP3131586A4
(en)
|
2014-03-18 |
2017-10-25 |
Madrigal Pharmaceuticals, Inc. |
Targeted therapeutics
|
|
ES2883023T3
(es)
*
|
2014-05-28 |
2021-12-03 |
Agensys Inc |
Derivados de péptidos de dolaproína-dolaisoleuina citotóxicos para el tratamiento del cáncer
|
|
US9950077B2
(en)
|
2014-06-20 |
2018-04-24 |
Bioalliance C.V. |
Anti-folate receptor alpha (FRA) antibody-drug conjugates and methods of using thereof
|
|
PL3169706T3
(pl)
|
2014-07-11 |
2020-05-18 |
Genmab A/S |
Przeciwciała wiążące axl
|
|
CN107108694B
(zh)
*
|
2014-09-11 |
2022-05-03 |
西雅图基因公司 |
含叔胺药物物质的靶向递送
|
|
KR102494557B1
(ko)
|
2014-09-17 |
2023-02-02 |
자임워크스 비씨 인코포레이티드 |
세포독성 및 항유사분열성 화합물, 그리고 이를 이용하는 방법
|
|
KR20230158134A
(ko)
|
2014-10-14 |
2023-11-17 |
폴리테릭스 리미티드 |
Peg의 일부를 포함하는 이탈기를 포함하는 시약을 사용한, 펩티드 또는 단백질의 접합방법
|
|
US10077287B2
(en)
|
2014-11-10 |
2018-09-18 |
Bristol-Myers Squibb Company |
Tubulysin analogs and methods of making and use
|
|
SG11201704458SA
(en)
*
|
2014-12-08 |
2017-06-29 |
Sorrento Therapeutics Inc |
C-met antibody drug conjugate
|
|
US9968683B2
(en)
|
2014-12-17 |
2018-05-15 |
Organolinx Corp. |
Method for conjugating molecules
|
|
CN107849090A
(zh)
*
|
2015-01-28 |
2018-03-27 |
索伦托医疗有限公司 |
抗体药物偶联物
|
|
WO2016127081A1
(en)
*
|
2015-02-06 |
2016-08-11 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates
|
|
BR112017016503A2
(pt)
*
|
2015-02-15 |
2018-04-10 |
Jiangsu Hengrui Medicine Co., Ltd. |
conjugado de fármaco de citotoxicidade-ligante, método de preparação para o mesmo, e aplicação para o mesmo
|
|
CN106279352B
(zh)
|
2015-05-29 |
2020-05-22 |
上海新理念生物医药科技有限公司 |
海兔毒素10的衍生物及其应用
|
|
US10449258B2
(en)
|
2015-06-09 |
2019-10-22 |
Xdcexplorer (Shanghai) Co., Ltd. |
Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof
|
|
CN108368171A
(zh)
|
2015-07-10 |
2018-08-03 |
根马布股份公司 |
用于癌症治疗的axl特异性抗体-药物缀合物
|
|
CA2991973C
(en)
|
2015-07-12 |
2021-12-07 |
Suzhou M-Conj Biotech Co., Ltd. |
Bridge linkers for conjugation of a cell-binding molecule
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
WO2017054080A1
(en)
*
|
2015-09-29 |
2017-04-06 |
Zymeworks Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
WO2017058808A1
(en)
*
|
2015-10-02 |
2017-04-06 |
Sirenas Llc |
Anti-cancer compounds and conjugates thereof
|
|
EP3165237B1
(en)
|
2015-11-03 |
2018-12-19 |
Industrial Technology Research Institute |
Antibody-drug conjugate (adc) and method for forming the same
|
|
CN106729743B
(zh)
*
|
2015-11-23 |
2021-09-21 |
四川科伦博泰生物医药股份有限公司 |
抗ErbB2抗体-药物偶联物及其组合物、制备方法和应用
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
CA3006000A1
(en)
|
2015-12-04 |
2017-06-08 |
Seattle Genetics, Inc. |
Conjugates of quaternized tubulysin compounds
|
|
MX395252B
(es)
|
2016-01-08 |
2025-03-25 |
Altrubio Inc |
Anticuerpos tetravalentes anti ligando-1 de glicoproteina p-selectina (psgl-1) y usos de estos.
|
|
CN107029244B
(zh)
*
|
2016-02-04 |
2021-04-27 |
浙江昭华生物医药有限公司 |
抗her2抗体-药物偶联物及其应用
|
|
RS62108B1
(sr)
|
2016-03-02 |
2021-08-31 |
Eisai R&D Man Co Ltd |
Antitelo-lek konjugati na bazi eribulina i postupci primene
|
|
JP7073266B2
(ja)
|
2016-03-25 |
2022-05-23 |
シージェン インコーポレイテッド |
Ｐｅｇ化薬物リンカー及びその中間体を調製するためのプロセス
|
|
EP3438118B1
(en)
*
|
2016-03-29 |
2023-03-29 |
Toray Industries, Inc. |
Peptide derivative and use thereof
|
|
US20170281758A1
(en)
*
|
2016-03-29 |
2017-10-05 |
Sorrento Therapeutics, Inc. |
Calicheamicin antibody drug conjugates linking an amidoacetyl group to a sugar moiety on calicheamicin
|
|
MA45328A
(fr)
|
2016-04-01 |
2019-02-06 |
Avidity Biosciences Llc |
Compositions acide nucléique-polypeptide et utilisations de celles-ci
|
|
CA3025931A1
(en)
*
|
2016-05-31 |
2017-12-07 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates having derivatives of amatoxin as the drug
|
|
US10111966B2
(en)
|
2016-06-17 |
2018-10-30 |
Magenta Therapeutics, Inc. |
Methods for the depletion of CD117+ cells
|
|
CN108697809A
(zh)
*
|
2016-08-23 |
2018-10-23 |
四川科伦博泰生物医药股份有限公司 |
一种抗体-药物偶联物及其制备方法和应用
|
|
US10517958B2
(en)
|
2016-10-04 |
2019-12-31 |
Zymeworks Inc. |
Compositions and methods for the treatment of platinum-drug resistant cancer
|
|
CN110088086B
(zh)
*
|
2016-11-25 |
2022-12-16 |
迈威(上海)生物科技股份有限公司 |
用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途
|
|
CN108101825B
(zh)
*
|
2016-11-25 |
2022-02-22 |
迈威(上海)生物科技股份有限公司 |
用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途
|
|
CN109810039B
(zh)
*
|
2017-11-22 |
2021-11-12 |
迈威(上海)生物科技股份有限公司 |
一种用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途
|
|
US10864279B2
(en)
|
2016-12-16 |
2020-12-15 |
Industrial Technology Research Institute |
Linker-drug and antibody-drug conjugate (ADC) employing the same
|
|
JP7573966B2
(ja)
|
2017-01-06 |
2024-10-28 |
アビディティー バイオサイエンシーズ，インク． |
エクソンスキッピングを誘導する核酸ポリペプチド組成物および方法
|
|
SG10202102897PA
(en)
|
2017-01-20 |
2021-04-29 |
Magenta Therapeutics Inc |
Compositions and methods for the depletion of cd137+ cells
|
|
US11730822B2
(en)
|
2017-03-24 |
2023-08-22 |
Seagen Inc. |
Process for the preparation of glucuronide drug-linkers and intermediates thereof
|
|
US20200069814A1
(en)
*
|
2017-04-06 |
2020-03-05 |
Hangzhou Dac Biotech Co., Ltd. |
Conjugation of a cytotoxic drug with bis-linkage
|
|
WO2018192407A1
(zh)
|
2017-04-19 |
2018-10-25 |
四川科伦博泰生物医药股份有限公司 |
细胞毒素和偶联物、其用途和制备方法
|
|
CA3067311A1
(en)
*
|
2017-06-20 |
2018-12-27 |
Sorrento Therapeutics, Inc. |
Cd38 antibody drug conjugate
|
|
KR20200016875A
(ko)
|
2017-06-20 |
2020-02-17 |
마드리갈 파마슈티칼스 인코포레이티드 |
표적화 치료제
|
|
IL299892A
(en)
|
2017-06-20 |
2023-03-01 |
Madrigal Pharmaceuticals Inc |
Combination therapies that include prescribed medications
|
|
GB201711809D0
(en)
|
2017-07-21 |
2017-09-06 |
Governors Of The Univ Of Alberta |
Antisense oligonucleotide
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
US10799598B2
(en)
|
2017-08-01 |
2020-10-13 |
Sorrento Therapeutics, Inc. |
Disulfide bridging conjugates
|
|
TWI799438B
(zh)
|
2017-08-10 |
2023-04-21 |
日商住友製藥股份有限公司 |
半星芒體衍生物及此等之抗體藥物複合體
|
|
MA50124A
(fr)
|
2017-09-08 |
2020-07-15 |
Seattle Genetics Inc |
Procédé de préparation de tubulysines et d'intermédiaires de celles-ci
|
|
CN118267396A
(zh)
|
2017-10-04 |
2024-07-02 |
艾维迪提生物科学公司 |
核酸-多肽组合物及其用途
|
|
KR102762352B1
(ko)
*
|
2017-11-30 |
2025-02-05 |
씨젠 인크. |
약물 링커 화합물의 제조방법
|
|
IL319835A
(en)
|
2017-12-06 |
2025-05-01 |
Avidity Biosciences Inc |
Compositions and methods for treating muscular dystrophy and myotonic dystrophy
|
|
CN120248020B
(zh)
|
2017-12-15 |
2025-10-03 |
四川科伦博泰生物医药股份有限公司 |
生物活性物偶联物及其制备方法和用途
|
|
WO2019149116A1
(zh)
*
|
2018-01-30 |
2019-08-08 |
四川科伦博泰生物医药股份有限公司 |
制备偶联物的方法
|
|
CN111989339A
(zh)
*
|
2018-02-20 |
2020-11-24 |
西雅图基因公司 |
疏水性奥瑞他汀f化合物及其缀合物
|
|
CN112367996B
(zh)
|
2018-06-01 |
2024-05-24 |
卫材R&D管理有限公司 |
使用剪接调节剂的方法
|
|
JP7390315B2
(ja)
|
2018-06-01 |
2023-12-01 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スプライシング調節薬抗体－薬物コンジュゲート及びその使用方法
|
|
WO2019246445A1
(en)
|
2018-06-20 |
2019-12-26 |
The Research Foundation For The State University Of New York |
Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same
|
|
SG11202103424UA
(en)
*
|
2018-10-12 |
2021-05-28 |
Hangzhou Dac Biotech Co Ltd |
Conjugation linkers containing 2,3-diaminosuccinyl group
|
|
WO2020081493A1
(en)
|
2018-10-16 |
2020-04-23 |
Molecular Templates, Inc. |
Pd-l1 binding proteins
|
|
CA3114931A1
(en)
|
2018-12-13 |
2020-06-18 |
Eisai R&D Management Co., Ltd. |
Herboxidiene antibody-drug conjugates and methods of use
|
|
IL319265A
(en)
|
2018-12-21 |
2025-04-01 |
Avidity Biosciences Inc |
Anti-transferrin receptor antibodies and their uses
|
|
US20220040320A1
(en)
*
|
2018-12-21 |
2022-02-10 |
Seagen Inc. |
Adcs with thiol multiplex linkers
|
|
CA3127113A1
(en)
|
2019-01-30 |
2020-08-06 |
Dongxu Sun |
Anti-gal3 antibodies and uses thereof
|
|
WO2020166600A1
(ja)
|
2019-02-13 |
2020-08-20 |
大日本住友製薬株式会社 |
システイン残基を有するヘミアスタリン誘導体
|
|
JP7479302B2
(ja)
|
2019-02-13 |
2024-05-08 |
住友ファーマ株式会社 |
ヘミアスタリン誘導体とその抗体薬物複合体
|
|
CN109824759A
(zh)
*
|
2019-03-08 |
2019-05-31 |
联宁（苏州）生物制药有限公司 |
一种用于抗体药物偶联物的药物-连接子mc-mmaf的制备方法及其中间体
|
|
CA3137715A1
(en)
|
2019-04-25 |
2020-10-29 |
Avidity Biosciences, Inc. |
Nucleic acid compositions and methods of multi-exon skipping
|
|
AU2020289464B2
(en)
|
2019-06-06 |
2025-12-04 |
Avidity Biosciences, Inc. |
Nucleic acid-polypeptide compositions and uses thereof
|
|
CN114375297A
(zh)
|
2019-06-06 |
2022-04-19 |
艾维迪提生物科学公司 |
Una亚酰胺及其用途
|
|
US11918649B2
(en)
|
2019-09-18 |
2024-03-05 |
Molecular Templates, Inc. |
PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds
|
|
WO2021144315A1
(en)
|
2020-01-13 |
2021-07-22 |
Synaffix B.V. |
Conjugates of antibodies an immune cell engagers
|
|
WO2021144314A1
(en)
|
2020-01-13 |
2021-07-22 |
Synaffix B.V. |
Via cycloaddition bilaterally functionalized antibodies
|
|
WO2021144313A1
(en)
|
2020-01-13 |
2021-07-22 |
Synaffix B.V. |
Via cycloaddition bilaterally functionalized antibodies
|
|
EP4110817A1
(en)
|
2020-02-26 |
2023-01-04 |
Sorrento Therapeutics, Inc. |
Activatable antigen binding proteins with universal masking moieties
|
|
CA3170633A1
(en)
*
|
2020-03-09 |
2021-09-16 |
David Goeddel |
Efficient preparation of dolastatin and auristatin analogs through a common intermediate
|
|
KR20220156867A
(ko)
|
2020-03-19 |
2022-11-28 |
어비디티 바이오사이언시스 인크. |
안면견갑상완 근이영양증의 치료용 조성물 및 방법
|
|
EP4126066B1
(en)
|
2020-03-27 |
2025-11-19 |
Avidity Biosciences, Inc. |
Compositions and methods of treating muscle dystrophy
|
|
US10987487B1
(en)
|
2020-04-29 |
2021-04-27 |
Cure Medical Llc |
Gripper sleeve for urinary catheter
|
|
JP2023528797A
(ja)
|
2020-05-26 |
2023-07-06 |
トゥルーバインディング，インコーポレイテッド |
ガレクチン－３を遮断することにより炎症性疾患を処置する方法
|
|
MX2022015374A
(es)
|
2020-06-05 |
2023-01-16 |
Eisai R&D Man Co Ltd |
Conjugados de anticuerpo anti antigeno de maduracion de linfocitos b (bcma)-farmaco y metodos de uso.
|
|
WO2021260232A1
(en)
|
2020-06-26 |
2021-12-30 |
Synaffix B.V. |
Methods for the preparation of linker payload constructs
|
|
NL2026400B1
(en)
|
2020-09-02 |
2022-05-04 |
Synaffix Bv |
Methods for the preparation of bioconjugates
|
|
CA3193584A1
(en)
|
2020-09-04 |
2022-03-10 |
Novarock Biotherapeutics, Ltd. |
Nectin-4 antibodies and uses thereof
|
|
WO2022058395A1
(en)
|
2020-09-15 |
2022-03-24 |
Synaffix B.V. |
Antibody-exatecan conjugates
|
|
NL2026947B1
(en)
|
2020-11-20 |
2022-07-01 |
Synaffix Bv |
Tyrosine-based antibody conjugates
|
|
MX2023007126A
(es)
|
2020-12-23 |
2023-09-04 |
Univ Muenchen Ludwig Maximilians |
Conjugados anticuerpo-droga mejorados dirigidos contra cd30 y usos de los mismos.
|
|
WO2022161452A1
(zh)
*
|
2021-01-28 |
2022-08-04 |
南京桦冠生物技术有限公司 |
缀合物及其用途
|
|
US20250262314A1
(en)
|
2021-02-08 |
2025-08-21 |
Synaffix B.V. |
Multifunctional antibodies
|
|
EP4301418A1
(en)
|
2021-03-03 |
2024-01-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates comprising an anti-bcma antibody
|
|
CA3213295A1
(en)
|
2021-03-17 |
2022-09-22 |
Molecular Templates, Inc. |
Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t cell antigens
|
|
CN116897149A
(zh)
*
|
2021-03-30 |
2023-10-17 |
上海复旦张江生物医药股份有限公司 |
一种连接基药物偶联物的制备方法及其中间体
|
|
US20250026838A1
(en)
|
2021-07-13 |
2025-01-23 |
Truebinding, Inc. |
Methods of preventing protein aggregation
|
|
EP4401792A4
(en)
|
2021-09-16 |
2025-12-03 |
Avidity Biosciences Inc |
COMPOSITIONS AND METHODS OF TREATMENT OF FACIO-SCAPULO-HUMERAL MUSCULAR DYSTROPHY
|
|
CN118524852A
(zh)
|
2021-11-09 |
2024-08-20 |
真和制药有限公司 |
治疗或抑制心血管疾病的方法
|
|
AU2022422149A1
(en)
|
2021-12-23 |
2024-08-01 |
Mirecule, Inc. |
Compositions for delivery of polynucleotides
|
|
EP4489790A1
(en)
|
2022-03-10 |
2025-01-15 |
Vivasor, Inc. |
Antibody-drug conjugates and uses thereof
|
|
US12071621B2
(en)
|
2022-04-05 |
2024-08-27 |
Avidity Biosciences, Inc. |
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
|
|
IL318625A
(en)
|
2022-07-29 |
2025-03-01 |
Regeneron Pharma |
Compositions and methods for transferrin receptor (TFR)-mediated delivery to brain and muscle
|
|
CN119997985A
(zh)
|
2022-08-15 |
2025-05-13 |
西纳福克斯股份有限公司 |
蒽环类药物及其缀合物
|
|
CN117801107A
(zh)
|
2022-09-30 |
2024-04-02 |
上海迪诺医药科技有限公司 |
苯并氮杂卓衍生物、含其的偶联物及其应用
|
|
US20240173426A1
(en)
|
2022-11-14 |
2024-05-30 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|
|
EP4389152A1
(en)
|
2022-12-23 |
2024-06-26 |
Synaffix B.V. |
Conjugates of pbd prodrugs
|
|
CN116621927B
(zh)
*
|
2023-01-09 |
2024-03-26 |
联宁（苏州）生物制药有限公司 |
带有伊喜替康和C-lock定点偶联基团的抗体偶联中间体、偶联方法及抗体偶联药物
|
|
EP4410313A1
(en)
|
2023-01-31 |
2024-08-07 |
Synaffix B.V. |
Homogeneous antibody-conjugates with high payload loading
|
|
EP4674840A1
(en)
|
2023-02-28 |
2026-01-07 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Chemical coupling linker and use thereof
|
|
WO2024211235A1
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024211234A1
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024211236A2
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
EP4450093A1
(en)
|
2023-04-17 |
2024-10-23 |
Synaffix B.V. |
Cleavable immune cell engagers
|
|
KR20250169628A
(ko)
|
2023-04-17 |
2025-12-03 |
시나픽스 비.브이. |
절단 가능한 면역 세포 인게이저
|
|
WO2025006639A2
(en)
|
2023-06-27 |
2025-01-02 |
Avidity Biosciences, Inc. |
Compositions and methods of using prkag2-targeting antibody-oligonucleotide conjugates abstract
|
|
WO2025007063A1
(en)
|
2023-06-30 |
2025-01-02 |
Avidity Biosciences, Inc. |
Compositions and methods of using pln-targeting antibody-oligonucleotide conjugates
|
|
WO2025027529A1
(en)
|
2023-07-31 |
2025-02-06 |
Advesya |
Anti-il-1rap antibody drug conjugates and methods of use thereof
|
|
TW202530255A
(zh)
|
2023-12-15 |
2025-08-01 |
法商亞維西亞有限公司 |
抗ｉｌ－１ｒａｐ結合結構域及其抗體－藥物偶聯物
|
|
CN117964682A
(zh)
*
|
2024-01-12 |
2024-05-03 |
杭州爱科瑞思生物医药有限公司 |
Dolastatin衍生物及其制备方法和应用
|
|
WO2025238253A1
(en)
|
2024-05-16 |
2025-11-20 |
Synaffix B.V. |
Antibody-oligonucleotide conjugates
|